Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.
Randomized Controlled Trial Evaluating the Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.
- Colonoscopy
- Colorectal Neoplasms
- Intestinal Polyps
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- University Hospital, Bordeaux
- Enrolment target
- 592
- Started
- 13 March 2026
- Main results due
- March 2031
- Study sites
- 15
- Registry updated
- 24 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Patients over 18 years of age with indication for colonoscopy as part of a screening program, after a positive immunological (FIT) test, and/or for personal or family history of colorectal cancer and/or personal history of colonic adenomas and/or sessile serrated polyp, * Written informed consent signed * Patients covered by a health-care insurance. Exclusion Criteria: * Failed complete colonoscopy, defined by the absence of cecal intubation or identification of the terminal ileum. * Inadequate bowel preparation (Boston bowel preparation score \< 6, and/or least at one part of colon with score ≤ 1) * An infiltrative tumor was diagnosed during colonoscope insertion time, not accessible to endoscopic resection and likely to require surgical management (a procedure where part of the colon may need to be removed). * Patient under guardianship or protection * Pregnant women * Not fluent in French or illiterate * Personal history of inflammatory bowel disease * Personal history of genetic predisposition of CRC * Personal history of major colorectal surgery involving total or subtotal colectomy
What this study is about
In the sponsor’s own words, from the registry.
The occurrence of interval cancers after colonoscopy raises the possibility of missed lesions. High- performance computer aided diagnosis (CAD) systems have been specially designed for the detection of colorectal lesions (CAD for detection is named CADe). The use of CADe improves adenoma detection in screening colonoscopy. The potential of CADe system in reducing the rate of progression to advanced polyps or interval cancer between two colonoscopies remains still uncertain.
Study sites(15)
CH de la Côte Basque
Bayonne, France
Not yet recruiting
CHU Brest la Cavale Blanche
Brest, France
Not yet recruiting
Hôpital de Carhaix
Carhaix-Plouguer, France
Not yet recruiting
Clinique Paris Bercy
Charenton-le-Pont, France
Not yet recruiting
CHU de Limoges
Limoges, France
Not yet recruiting
Institut Paoli Calmettes
Marseille, France
Not yet recruiting
Clinique Jules Verne
Nantes, France
Not yet recruiting
CHU Nîmes
Nîmes, France
Not yet recruiting
APHP - Hôpital Saint Antoine
Paris, France
Not yet recruiting
Aphp-Hegp
Paris, France
Not yet recruiting
APHP - Hôpital Tenon
Paris, France
Not yet recruiting
CHU Bordeaux - Hôpital Haut Lévêque
Pessac, France
Recruiting
CHU de Rennes
Rennes, France
Not yet recruiting
Clinique Pasteur
Toulouse, France
Not yet recruiting
CHRU de Nancy - Hôpital Brabois Adultes
Vandœuvre-lès-Nancy, France
Not yet recruiting
Showing 15 of 15 sites. 1 of the 15 sites on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07299071. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me